IL-25 prevents and cures fulminant hepatitis in mice through a myeloid-derived suppressor cell-dependent mechanism

作者: Massimiliano Sarra , Maria Laura Cupi , Roberta Bernardini , Giulia Ronchetti , Ivan Monteleone

DOI: 10.1002/HEP.26446

关键词:

摘要: Fulminant hepatitis (FH) is a disease characterized by massive destruction of hepatocytes with severe impairment liver function. The pathogenesis FH not fully understood, but hyperactivity T cells and macrophages excessive production cytokines are important hallmarks the condition. In this study, we investigated role interleukin (IL)−25 in FH. IL-25 expression was evaluated patients livers mice induced D-galactosamine (D-Gal) lipopolysaccharide (LPS). Mice were treated before D-Gal/LPS-induced or after concanavalin A (ConA)-induced Mononuclear isolated from without analyzed for GR1+CD11b+ cells. CFSE-labeled cocultured their proliferation flow cytometry. also depleting anti-GR1 antibody D-Gal/LPS administration. constitutively expressed mouse human down-regulated during prevented effect associated increased infiltration coexpressing GR1 CD11b. vitro studies showed that given inhibited T-cell proliferation. Consistently, vivo depletion GR1+ abrogated protective experimental both preventive therapeutic ConA-induced Conclusions: markedly reduced promotes accumulation GR1+CD11b+cells immunoregulatory properties. (Hepatology 2013;58:1436–1450)

参考文章(35)
Zhong-Jun Dong, Hai-Ming Wei, Rui Sun, Bin Gao, Zhi-Gang Tian, Isolation of murine hepatic lymphocytes using mechanical dissection for phenotypic and functional analysis of NK1.1 + cells World Journal of Gastroenterology. ,vol. 10, pp. 1928- 1933 ,(2004) , 10.3748/WJG.V10.I13.1928
Stephanie K. Bunt, Pratima Sinha, Virginia K. Clements, Jeff Leips, Suzanne Ostrand-Rosenberg, Inflammation Induces Myeloid-Derived Suppressor Cells that Facilitate Tumor Progression Journal of Immunology. ,vol. 176, pp. 284- 290 ,(2006) , 10.4049/JIMMUNOL.176.1.284
Y Watanabe, M Morita, T Akaike, Concanavalin A induces perforin-mediated but not Fas-mediated hepatic injury Hepatology. ,vol. 24, pp. 702- 710 ,(1996) , 10.1002/HEP.510240338
Lauren A. Zenewicz, George D. Yancopoulos, David M. Valenzuela, Andrew J. Murphy, Margaret Karow, Richard A. Flavell, Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. Immunity. ,vol. 27, pp. 647- 659 ,(2007) , 10.1016/J.IMMUNI.2007.07.023
R. Todd Stravitz, David J. Kramer, Management of acute liver failure. Nature Reviews Gastroenterology & Hepatology. ,vol. 6, pp. 542- 553 ,(2009) , 10.1038/NRGASTRO.2009.127
Richard Silverstein, D-galactosamine lethality model: scope and limitations. Journal of Endotoxin Research. ,vol. 10, pp. 147- 162 ,(2004) , 10.1179/096805104225004879
Tim F. Greten, Michael P. Manns, Firouzeh Korangy, Myeloid derived suppressor cells in human diseases International Immunopharmacology. ,vol. 11, pp. 802- 807 ,(2011) , 10.1016/J.INTIMP.2011.01.003
Thomas Condamine, Dmitry I. Gabrilovich, Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function Trends in Immunology. ,vol. 32, pp. 19- 25 ,(2011) , 10.1016/J.IT.2010.10.002
Fanli Meng, Kai Wang, Tomonori Aoyama, Sergei I. Grivennikov, YongHan Paik, David Scholten, Min Cong, Keiko Iwaisako, Xiao Liu, Mingjun Zhang, Christoph H. Österreicher, Felix Stickel, Klaus Ley, David A. Brenner, Tatiana Kisseleva, Interleukin-17 Signaling in Inflammatory, Kupffer Cells, and Hepatic Stellate Cells Exacerbates Liver Fibrosis in Mice Gastroenterology. ,vol. 143, pp. 765- 776 ,(2012) , 10.1053/J.GASTRO.2012.05.049
Giovanni Monteleone, Francesco Pallone, Thomas T. MacDonald, Interleukin-25: a two-edged sword in the control of immune-inflammatory responses. Cytokine & Growth Factor Reviews. ,vol. 21, pp. 471- 475 ,(2010) , 10.1016/J.CYTOGFR.2010.05.001